Anticoagulation Strategies and Filter Life in COVID-19 Patients Receiving Continuous Renal Replacement Therapy: A Single-Center Experience.
作者信息
Shankaranarayanan Divya, Muthukumar Thangamani, Barbar Tarek, Bhasin Aarti, Gerardine Supriya, Lamba Perola, Leuprecht Lorenz, Neupane Sanjay P, Salinas Thalia, Shimonov Daniil, Varma Elly, Liu Frank
机构信息
Division of Nephrology and Hypertension, Weill Cornell Medicine, New York, New York.
Department of Medicine, Weill Cornell Medicine, New York, New York.
出版信息
Clin J Am Soc Nephrol. 2020 Dec 31;16(1):124-126. doi: 10.2215/CJN.08430520. Epub 2020 Sep 17.
Abstract
摘要
相似文献
1
Anticoagulation Strategies and Filter Life in COVID-19 Patients Receiving Continuous Renal Replacement Therapy: A Single-Center Experience.接受连续性肾脏替代治疗的COVID-19患者的抗凝策略与滤器寿命：单中心经验
Clin J Am Soc Nephrol. 2020 Dec 31;16(1):124-126. doi: 10.2215/CJN.08430520. Epub 2020 Sep 17.
2
Comparison of different anticoagulation strategies for renal replacement therapy in critically ill patients with COVID-19: a cohort study.比较 COVID-19 危重症患者肾替代治疗中不同抗凝策略的队列研究。
BMC Nephrol. 2020 Nov 16;21(1):486. doi: 10.1186/s12882-020-02150-8.
3
Continuous renal replacement therapy in COVID-19-associated AKI: adding heparin to citrate to extend filter life-a retrospective cohort study.COVID-19 相关急性肾损伤的连续性肾脏替代治疗：在柠檬酸盐中添加肝素以延长滤器寿命——一项回顾性队列研究。
Crit Care. 2021 Aug 19;25(1):299. doi: 10.1186/s13054-021-03729-9.
4
Acute Kidney Injury and Special Considerations during Renal Replacement Therapy in Children with Coronavirus Disease-19: Perspective from the Critical Care Nephrology Section of the European Society of Paediatric and Neonatal Intensive Care.儿童 2019 冠状病毒病急性肾损伤及肾脏替代治疗的特殊考虑：来自欧洲儿童和新生儿重症监护学会重症肾脏病学组的观点。
Blood Purif. 2021;50(2):150-160. doi: 10.1159/000509677. Epub 2020 Jul 14.
5
Anticoagulation in COVID-19 patients requiring continuous renal replacement therapy.需要持续肾脏替代治疗的COVID-19患者的抗凝治疗
Anaesth Crit Care Pain Med. 2021 Jun;40(3):100841. doi: 10.1016/j.accpm.2021.100841. Epub 2021 Mar 19.
6
Deployment of a New CRRT/PIRRT Device during the COVID-19 Pandemic Emergency: Organizational Challenges and Implementation Results.COVID-19 大流行紧急情况下新型 CRRT/PIRRT 设备的部署：组织挑战和实施结果。
Blood Purif. 2021;50(3):390-398. doi: 10.1159/000511726. Epub 2020 Nov 10.
7
Effect of Regional Citrate Anticoagulation vs Systemic Heparin Anticoagulation During Continuous Kidney Replacement Therapy on Dialysis Filter Life Span and Mortality Among Critically Ill Patients With Acute Kidney Injury: A Randomized Clinical Trial.局部枸橼酸抗凝与全身肝素抗凝对连续性肾脏替代治疗中急性肾损伤危重症患者透析滤器寿命和死亡率的影响：一项随机临床试验。
JAMA. 2020 Oct 27;324(16):1629-1639. doi: 10.1001/jama.2020.18618.
8
Dialysis circuit clotting in critically ill patients with COVID-19 infection.COVID-19 感染危重症患者的透析回路凝血。
BMC Nephrol. 2021 Apr 20;22(1):141. doi: 10.1186/s12882-021-02357-3.
9
Pharmacological interventions for preventing clotting of extracorporeal circuits during continuous renal replacement therapy.连续肾脏替代治疗期间预防体外循环凝血的药理学干预措施。
Cochrane Database Syst Rev. 2020 Mar 13;3(3):CD012467. doi: 10.1002/14651858.CD012467.pub2.
10
Anticoagulation strategies in continuous renal replacement therapy.连续性肾脏替代治疗中的抗凝策略。
Semin Dial. 2021 Nov;34(6):416-422. doi: 10.1111/sdi.12959. Epub 2021 Mar 8.
引用本文的文献
1
Comparison of different anticoagulation methods in continuous renal replacement therapy for pediatric acute liver failure patients: a retrospective observational study.小儿急性肝衰竭患者连续性肾脏替代治疗中不同抗凝方法的比较：一项回顾性观察研究
Front Pediatr. 2025 Aug 26;13:1667760. doi: 10.3389/fped.2025.1667760. eCollection 2025.
2
Efficacy and safety of low-molecular-weight-heparin plus citrate in nephrotic syndrome during continuous kidney replacement therapy: retrospective study.低分子量肝素联合枸橼酸盐在连续性肾脏替代治疗肾病综合征中的疗效及安全性：回顾性研究
PeerJ. 2025 Feb 25;13:e18919. doi: 10.7717/peerj.18919. eCollection 2025.
3
How to safeguard the continuous renal replacement therapy circuit: a narrative review.如何保障连续性肾脏替代治疗回路：一篇叙述性综述
Front Med (Lausanne). 2024 Aug 21;11:1442065. doi: 10.3389/fmed.2024.1442065. eCollection 2024.
4
Citrate and low-dose heparin combined anticoagulation in pediatric continuous renal replacement therapy.柠檬酸盐与小剂量肝素联合抗凝在儿科连续性肾脏替代治疗中的应用。
Sci Rep. 2024 Jun 12;14(1):13504. doi: 10.1038/s41598-024-64433-6.
5
Knowledge, attitude, practice, needs, and implementation status of intensive care unit staff toward continuous renal replacement therapy: a survey of 66 hospitals in central and South China.重症监护病房工作人员对连续性肾脏替代治疗的知识、态度、实践、需求及实施现状：对中国中部和南部66家医院的调查
BMC Nurs. 2024 Apr 26;23(1):281. doi: 10.1186/s12912-024-01953-6.
6
Dialysis resource allocation in critical care: the impact of the COVID-19 pandemic and the promise of big data analytics.重症监护中的透析资源分配：COVID-19大流行的影响及大数据分析的前景
Front Nephrol. 2023 Oct 26;3:1266967. doi: 10.3389/fneph.2023.1266967. eCollection 2023.
7
The Role of Anticoagulants and Antiplatelets in Reducing Mortality in COVID-19 Patients: A Systematic Review and Meta-Analysis of Studies Reporting Adjusted Data.抗凝剂和抗血小板药物在降低COVID-19患者死亡率中的作用：对报告校正数据的研究的系统评价和荟萃分析
Cureus. 2023 Sep 22;15(9):e45749. doi: 10.7759/cureus.45749. eCollection 2023 Sep.
8
Effect of extracorporeal hemoadsorption in critically ill patients with COVID-19: A narrative review.体外血液吸附治疗 COVID-19 危重症患者的效果：一项叙述性综述。
Front Immunol. 2023 Feb 3;14:1074465. doi: 10.3389/fimmu.2023.1074465. eCollection 2023.
9
CVVHD results in longer filter life than pre-filter CVVH: Results of a quasi-randomized clinical trial.CVVHD 比预滤 CVVH 更能延长滤器寿命：一项准随机临床试验结果。
PLoS One. 2023 Jan 11;18(1):e0278550. doi: 10.1371/journal.pone.0278550. eCollection 2023.
10
Results of the 2018 Japan Society for Blood Purification in Critical Care survey: current status and outcomes.2018年日本重症监护血液净化学会调查结果：现状与成果
Ren Replace Ther. 2022;8(1):58. doi: 10.1186/s41100-022-00445-0. Epub 2022 Nov 12.
Zotero 插件